Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02229305 · ClinicalTrials.gov registry record · NA

Maine Implementation Study - Phase III

A NA study, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
235
Enrollment target

NCT02229305 is a NA study that has completed, run by Harvard University. The registered enrollment target is 235 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02229305, a NA study, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
235 participants
Enrollment target

Study Summary

This study focused on youths who were referred to community-based mental healths clinics for problems related to disruptive behaviors, depression, anxiety, traumatic stress, and any combination of these problems. Therapists were randomly assigned to deliver usual treatment procedures (usual care, or UC) in their clinics or an evidence-based, modularized treatment (Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, or Conduct Problems, or MATCH-ADTC). Assessments were conducted at pre-treatment and post-treatment, and every 3 to 6 months for two years. Results will address critical questions about deployment of evidence-based youth practices to clinical settings.

Interventions

  • BEHAVIORAL Usual Care Treatment
  • BEHAVIORAL Modular Approach to Therapy for Children

Trial Details

FieldValue
Enrollment Target 235 participants
Start Date 2008-12
Est. Completion 2012-10
Phase NA

Sponsor

Harvard University

37 total trials

What the Registry Record Tells You About NCT02229305

The ClinicalTrials.gov registry entry for NCT02229305 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care Treatment is the first listed.

NCT02229305 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02229305 about?

NCT02229305 is a clinical study titled "Maine Implementation Study - Phase III". This study focused on youths who were referred to community-based mental healths clinics for problems related to disruptive behaviors, depression, anxiety, traumatic stress, and any combination of these problems. Therapists were randomly assigned to deliver usual treatment procedures (usual care, or...

What is the current status of trial NCT02229305?

This trial is currently completed. It is a NA study. The enrollment target is 235 participants. The study started on 2008-12. Estimated completion is 2012-10.

What interventions are being tested in trial NCT02229305?

The interventions under investigation include: Usual Care Treatment (BEHAVIORAL), Modular Approach to Therapy for Children (BEHAVIORAL).

Who is sponsoring clinical trial NCT02229305?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.